As expected, the cytotoxicity of D@C-LPs towards cancer cells varied according to the expression of CLDN4, with more severe cytotoxicity observed in CLDN4-positive ASPC-1 and KPC960 cells compared with CLDN4-negative A549 cells (Fig. 3B). This evidence concerns the gene CLDN4 and cancer.